Leuprorelin

Leuprolide is a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors.

Larazotide Structure

Name: Leuprorelin; Leuprolide; Eligard; Leuprorelina; Leuproreline; Leuprorelinum
CAS No.: 74381-53-6
Peptide Sequence: H-Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
Molecular Formula: C59H84N16O12
Molecular Weight: 1209.4
Appearance: White Lyophilized powder

Leuprorelin Overview

Leuprolide is a parenterally administered, gonadotropin releasing hormone (GnRH) agonist which causes an inhibition of estrogen and androgen production and is used predominantly to treat advanced prostate cancer. Leuprolide has been associated with a modest rate of serum enzyme elevations during therapy, but has not been convincingly linked to instances of clinically apparent acute liver injury.

Product use: This product is only for research chemicals.

PREVIOUS：PEG-MGF NEXT：Acetyl Hexapeptide-49